Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05091931 · ClinicalTrials.gov registry record
Diagnosis, Antibiotic Prescribing Practices and Outcomes of cUTI in an Outpatient Setting
A clinical trial, sponsored by Pathnostics.
- Completed
- Registry status
- 3,308
- Enrollment target
NCT05091931 is a clinical trial that has completed, run by Pathnostics. The registered enrollment target is 3,308 participants.
The verdict
NCT05091931 has completed, sponsored by Pathnostics.
- COMPLETED
- Registry status
- 3,308 participants
- Enrollment target
Study Summary
This prospective, multicenter, comparative cohort observational study is to determine if Guidance® UTI pathway compared to traditional diagnostic pathways reduces the rates of empiric antibiotic therapy, adverse events, and improves therapeutic accuracy of treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,308 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2024-09-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05091931
The ClinicalTrials.gov registry entry for NCT05091931 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,308 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pathnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05091931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05091931 about?
NCT05091931 is a clinical study titled "Diagnosis, Antibiotic Prescribing Practices and Outcomes of cUTI in an Outpatient Setting". This prospective, multicenter, comparative cohort observational study is to determine if Guidance® UTI pathway compared to traditional diagnostic pathways reduces the rates of empiric antibiotic therapy, adverse events, and improves therapeutic accuracy of treatment
What is the current status of trial NCT05091931?
This trial is currently completed. The enrollment target is 3,308 participants. The study started on 2022-03-28. Estimated completion is 2024-09-19.
Who is sponsoring clinical trial NCT05091931?
This trial is sponsored by Pathnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.